Biography

Dr. Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. She is an Associate Professor at the University of Toronto in the Institute of Health Policy Management and Evaluation.  Her research focuses on evaluating the adoption of new genomic technologies in clinical practice. She develops patient-facing digital tools for genomic medicine and evaluates their comparative effectiveness to inform translation in clinical practice. She also conducts public and patient engagement research to advance health technology assessment and health service delivery. Dr. Bombard is active in numerous international policy advisory committees; her research informs policy development in this area.  Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a ‘Rising Star’ award from CIHR’s Institute of Health Services and Policy Research. She has been awarded a CIHR Foundation grant as an Early Career Investigator, and she holds a CIHR New Investigator Award.

Dr. Bombard holds a Fellowship from Yale University (Health Policy), a Fellowship from the Memorial Sloan-Kettering Cancer Center (Cancer Genomics) and a Fellowship from the University of Toronto (Health Services Research).

Recent Publications

  1. Shickh, S, Hirjikaka, D, Clausen, M, Kodida, R, Mighton, C, Reble, E et al.. Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery. BMJ Open. 2022;12 (4):e060899. doi: 10.1136/bmjopen-2022-060899. PubMed PMID:35487723 PubMed Central PMC9058789.
  2. Shickh, S, Oldfield, LE, Clausen, M, Mighton, C, Sebastian, A, Calvo, A et al.. "Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management. Oncologist. 2022;27 (5):e393-e401. doi: 10.1093/oncolo/oyac039. PubMed PMID:35385106 PubMed Central PMC9075003.
  3. Sebastian, A, Carroll, JC, Vanstone, M, Clausen, M, Kodida, R, Reble, E et al.. Challenges and practical solutions for managing secondary genomic findings in primary care. Eur J Med Genet. 2022;65 (1):104384. doi: 10.1016/j.ejmg.2021.104384. PubMed PMID:34768014 .
  4. Taher, J, Mighton, C, Chowdhary, S, Casalino, S, Frangione, E, Arnoldo, S et al.. Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort study. BMJ Open. 2021;11 (9):e052842. doi: 10.1136/bmjopen-2021-052842. PubMed PMID:34593505 PubMed Central PMC8487020.
  5. Tiller, JM, Keogh, LA, McInerney-Leo, AM, Belcher, A, Barlow-Stewart, K, Boughtwood, T et al.. A step forward, but still inadequate: Australian health professionals' views on the genetics and life insurance moratorium. J Med Genet. 2021; :. doi: 10.1136/jmedgenet-2021-107989. PubMed PMID:34544841 .
  6. Mighton, C, Clausen, M, Sebastian, A, Muir, SM, Shickh, S, Baxter, NN et al.. Patient and public preferences for being recontacted with updated genomic results: a mixed methods study. Hum Genet. 2021;140 (12):1695-1708. doi: 10.1007/s00439-021-02366-0. PubMed PMID:34537903 .
  7. Joly, Y, Huerne, K, Arych, M, Bombard, Y, De Paor, A, Dove, ES et al.. The Genetic Discrimination Observatory: confronting novel issues in genetic discrimination. Trends Genet. 2021;37 (11):951-954. doi: 10.1016/j.tig.2021.08.004. PubMed PMID:34503867 .
  8. Shickh, S, Mighton, C, Uleryk, E, Pechlivanoglou, P, Bombard, Y. The clinical utility of exome and genome sequencing across clinical indications: a systematic review. Hum Genet. 2021;140 (10):1403-1416. doi: 10.1007/s00439-021-02331-x. PubMed PMID:34368901 .
  9. Mahmood, S, Law, S, Bombard, Y. "I have to start learning how to live with becoming sick": A scoping review of the lived experiences of people with Huntington's disease. Clin Genet. 2022;101 (1):3-19. doi: 10.1111/cge.14024. PubMed PMID:34216010 .
  10. Clark, R, Kenk, M, McAlpine, K, Thain, E, Farncombe, KM, Pritchard, CC et al.. The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat. Can Urol Assoc J. 2021;15 (12):E623-E629. doi: 10.5489/cuaj.7383. PubMed PMID:34171218 PubMed Central PMC8631832.
Search PubMed

Affiliations & Other Activities

  • Associate Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Member, Board of Directors, American Society of Human Genetics
  • Member, CIHR Institute of Genetics Advisory Board
  • Member, Ontario Genetics Advisory Committee, Health Quality Ontario
  • Member, Board of Directors, Exactis Innovation
  • Associate, Ontario Institute of Cancer Research
  • Co-lead, Societal Values and Patient Engagement Program, the Canadian Centre for Applied Research in Cancer Control
  • Member, Provincial Council for Maternal and Child Health’s Prenatal Screening Advisory Committee
  • Member, Steering Committee of the Canadian Coalition for Genetic Fairness
X